- Daniela Kroshinsky, MD
Daniela Kroshinsky, MD
- Assistant Professor of Dermatology
- Harvard Medical School
Pernio (also known as chilblains or perniosis) is a condition characterized by the development of cold-induced erythrocyanotic skin lesions. The word "chilblains" may be derived from the Old English words "chill" and "blegen" (sore) .
Pernio manifests as erythematous to violaceous macules, papules, plaques, or nodules in sites of cold exposure. The most common sites for involvement are the fingers and toes (picture 1A-E). Symptoms of pruritus, pain, or burning often accompany the skin lesions, and complications of blistering, ulceration, or secondary infection can occur.
In many patients, pernio presents as an acute eruption that begins 12 to 24 hours after cold exposure and resolves within a few weeks. However, pernio may also follow a chronic or recurrent course. Treatment primarily involves protection of affected areas from cold environments.
The clinical features, diagnosis, and management of pernio will be reviewed here. Pernio is distinct from lupus pernio, a form of cutaneous sarcoidosis. Lupus pernio is discussed separately. (See "Cutaneous manifestations of sarcoidosis", section on 'Lupus pernio'.)
Data on the epidemiology of pernio are limited. Pernio usually occurs following exposure to cold, damp environments, and thus is most common among individuals who live in cold climates. Symptoms commonly begin in early winter and resolve by spring as cold exposure decreases. However, patients may develop recurrences during subsequent winters or persistent disease [2-4].To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Hedrich CM, Fiebig B, Hauck FH, et al. Chilblain lupus erythematosus--a review of literature. Clin Rheumatol 2008; 27:949.
- Souwer IH, Lagro-Janssen AL. Chronic chilblains. BMJ 2011; 342:d2708.
- Takci Z, Vahaboglu G, Eksioglu H. Epidemiological patterns of perniosis, and its association with systemic disorder. Clin Exp Dermatol 2012; 37:844.
- Padeh S, Gerstein M, Greenberger S, Berkun Y. Chronic chilblains: the clinical presentation and disease course in a large paediatric series. Clin Exp Rheumatol 2013; 31:463.
- Cappel JA, Wetter DA. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011. Mayo Clin Proc 2014; 89:207.
- Prakash S, Weisman MH. Idiopathic chilblains. Am J Med 2009; 122:1152.
- Guadagni M, Nazzari G. Acute perniosis in elderly people: a predictive sign of systemic disease? Acta Derm Venereol 2010; 90:544.
- Simon TD, Soep JB, Hollister JR. Pernio in pediatrics. Pediatrics 2005; 116:e472.
- White KP, Rothe MJ, Milanese A, Grant-Kels JM. Perniosis in association with anorexia nervosa. Pediatr Dermatol 1994; 11:1.
- Ayli EE, Ingraffea A, Weinman M, Gloster HM Jr. Chilblains in a Mohs histotechnician. Dermatol Surg 2012; 38:1555.
- Doutre MS, Beylot C, Beylot J, et al. Chilblain lupus erythematosus: report of 15 cases. Dermatology 1992; 184:26.
- Viguier M, Pinquier L, Cavelier-Balloy B, et al. Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine (Baltimore) 2001; 80:180.
- Lutz V, Cribier B, Lipsker D. Chilblains and antiphospholipid antibodies: report of four cases and review of the literature. Br J Dermatol 2010; 163:645.
- Weston WL, Morelli JG. Childhood pernio and cryoproteins. Pediatr Dermatol 2000; 17:97.
- Yang X, Perez OA, English JC 3rd. Adult perniosis and cryoglobulinemia: a retrospective study and review of the literature. J Am Acad Dermatol 2010; 62:e21.
- King JM, Plotner AN, Adams BB. Perniosis induced by a cold-therapy system. Arch Dermatol 2012; 148:1101.
- Ozmen M, Kurtoglu V, Can G, et al. The capillaroscopic findings in idiopathic pernio: is it a microvascular disease? Mod Rheumatol 2013; 23:897.
- Boada A, Bielsa I, Fernández-Figueras MT, Ferrándiz C. Perniosis: clinical and histopathological analysis. Am J Dermatopathol 2010; 32:19.
- Cribier B, Djeridi N, Peltre B, Grosshans E. A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 2001; 45:924.
- Crowson AN, Magro CM. Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases. Hum Pathol 1997; 28:478.
- Su WP, Perniciaro C, Rogers RS 3rd, White JW Jr. Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis 1994; 54:395.
- Günther C, Hillebrand M, Brunk J, Lee-Kirsch MA. Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol 2013; 69:e179.
- Quesada-Cortés A, Campos-Muñoz L, Díaz-Díaz RM, Casado-Jiménez M. Cold panniculitis. Dermatol Clin 2008; 26:485.
- Nousari HC, Kimyai-Asadi A, Anhalt GJ. Chronic idiopathic acrocyanosis. J Am Acad Dermatol 2001; 45:S207.
- Prendiville JS, Crow YJ. Blue (or purple) toes: chilblains or chilblain lupus-like lesions are a manifestation of Aicardi-Goutières syndrome and familial chilblain lupus. J Am Acad Dermatol 2009; 61:727.
- Vano-Galvan S, Martorell A. Chilblains. CMAJ 2012; 184:67.
- Ganor S. Corticosteroid therapy for pernio. J Am Acad Dermatol 1983; 8:136.
- Rustin MH, Newton JA, Smith NP, Dowd PM. The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. Br J Dermatol 1989; 120:267.
- Dowd PM, Rustin MH, Lanigan S. Nifedipine in the treatment of chilblains. Br Med J (Clin Res Ed) 1986; 293:923.
- Al-Sudany NK. Treatment of primary perniosis with oral pentoxifylline (a double-blind placebo-controlled randomized therapeutic trial). Dermatol Ther 2016; 29:263.
- ASSOCIATED DISORDERS
- CLINICAL MANIFESTATIONS
- History and physical examination
- Skin biopsy
- - Histopathology
- Additional evaluation
- DIFFERENTIAL DIAGNOSIS
- Chilblain lupus erythematosus
- Other disorders
- First-line therapy
- Other interventions
- SUMMARY AND RECOMMENDATIONS